Advertisement
Advertisement

STIM

STIM logo

Neuronetics, Inc. Common Stock

2.06
USD
Sponsored
+0.10
+5.36%
Jan 09, 15:59 UTC -5
Closed
exchange

After-Market

2.12

+0.05
+2.62%

STIM Earnings Reports

Positive Surprise Ratio

STIM beat 17 of 30 last estimates.

57%

Next Report

Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
$41.48M
/
-$0.10
Implied change from Q3 25 (Revenue/ EPS)
+11.22%
/
-23.08%
Implied change from Q4 24 (Revenue/ EPS)
+84.41%
/
-69.70%

Neuronetics, Inc. Common Stock earnings per share and revenue

On Nov 04, 2025, STIM reported earnings of -0.13 USD per share (EPS) for Q3 25, missing the estimate of -0.12 USD, resulting in a -0.62% surprise. Revenue reached 37.30 million, compared to an expected 38.60 million, with a -3.38% difference. The market reacted with a +3.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 41.48 million USD, implying an decrease of -23.08% EPS, and increase of 11.22% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
For Q3 2025, Neuronetics, Inc. Common Stock reported EPS of -$0.13, missing estimates by -0.62%, and revenue of $37.30M, -3.38% below expectations.
The stock price moved up 3.61%, changed from $2.77 before the earnings release to $2.87 the day after.
The next earning report is scheduled for Mar 02, 2026.
Based on 5 analysts, Neuronetics, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $41.48M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement